| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 5/6 |
China Chemical & Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$22.75 |
| 52 Week High | NT$28.00 |
| 52 Week Low | NT$22.10 |
| Beta | 0.13 |
| 1 Month Change | -3.60% |
| 3 Month Change | -7.33% |
| 1 Year Change | -13.50% |
| 3 Year Change | -2.57% |
| 5 Year Change | 21.01% |
| Change since IPO | -33.93% |
Recent News & Updates
Recent updates
Here's Why We Think China Chemical & Pharmaceutical (TPE:1701) Is Well Worth Watching
Apr 25
We Think China Chemical & Pharmaceutical (TPE:1701) Can Stay On Top Of Its Debt
Apr 07The China Chemical & Pharmaceutical (TPE:1701) Share Price Is Up 34% And Shareholders Are Holding On
Mar 17China Chemical & Pharmaceutical Co., Ltd.'s (TPE:1701) Stock Has Shown A Decent Performance: Have Financials A Role To Play?
Feb 24Is China Chemical & Pharmaceutical Co., Ltd. (TPE:1701) A Good Fit For Your Dividend Portfolio?
Jan 27
Does China Chemical & Pharmaceutical (TPE:1701) Have A Healthy Balance Sheet?
Jan 06The China Chemical & Pharmaceutical (TPE:1701) Share Price Is Up 22% And Shareholders Are Holding On
Dec 16China Chemical & Pharmaceutical Co., Ltd. (TPE:1701) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Nov 26Shareholder Returns
| 1701 | TW Pharmaceuticals | TW Market | |
|---|---|---|---|
| 7D | 0.2% | 8.5% | 1.1% |
| 1Y | -13.5% | 12.1% | 27.3% |
Rentabilidad frente al sector: 1701 obtuvo unos resultados inferiores a los del sector TW Pharmaceuticals , que el año pasado arrojó un rendimiento del 6.4%.
Rentabilidad vs. Mercado: 1701 obtuvo unos resultados inferiores a los del mercado TW, que fue del 20.7% el año pasado.
Price Volatility
| 1701 volatility | |
|---|---|
| 1701 Average Weekly Movement | 1.8% |
| Pharmaceuticals Industry Average Movement | 4.0% |
| Market Average Movement | 4.2% |
| 10% most volatile stocks in TW Market | 8.1% |
| 10% least volatile stocks in TW Market | 1.9% |
Precio estable de las acciones: 1701 no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de 1701 (4%) se ha mantenido estable durante el año pasado.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1952 | n/a | Chih-Yung Wu | https://www.ccpc.com.tw |
China Chemical & Pharmaceutical Co., Ltd. se dedica a la investigación y desarrollo, fabricación y venta de productos farmacéuticos y sanitarios genéricos para humanos y animales. La empresa suministra suplementos para la función sexual; fármacos cardiovasculares, antilipidémicos y para el alivio de impedimentos circulatorios periféricos; fármacos para el tratamiento de la diabetes, esteroides adrenocorticoides y fármacos para el control de peso; y fármacos antiinfecciosos, como antibióticos, antifúngicos y antivirales.
China Chemical & Pharmaceutical Co., Ltd. Fundamentals Summary
| 1701 fundamental statistics | |
|---|---|
| Market cap | NT$6.76b |
| Earnings (TTM) | NT$322.29m |
| Revenue (TTM) | NT$8.57b |
21.0x
P/E Ratio0.8x
P/S RatioIs 1701 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1701 income statement (TTM) | |
|---|---|
| Revenue | NT$8.57b |
| Cost of Revenue | NT$5.43b |
| Gross Profit | NT$3.14b |
| Other Expenses | NT$2.82b |
| Earnings | NT$322.29m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.08 |
| Gross Margin | 36.62% |
| Net Profit Margin | 3.76% |
| Debt/Equity Ratio | 41.2% |
How did 1701 perform over the long term?
See historical performance and comparison